DAPSONE

Course overview

DAPSONE IS INDICATED FOR A VARIETY OF CONDITIONS, BOTH DERMATOLOGIC AND NON-DERMATOLOGIC. THE FDA-APPROVED INDICATIONS ARE LEPROSY AND DERMATITIS HERPETIFORMIS. THE NON-FDA APPROVED INDICATIONS INCLUDE A WIDE RANGE OF DERMATOSES, AS WELL AS MALARIA AND PNEUMOCYSTIS (CARINII) JIROVECI PROPHYLAXIS AND TREATMENT. THIS ACTIVITY REVIEWS THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, TOXICITY, DOSING, PHARMACODYNAMICS, AND MONITORING OF DAPSONE, PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN TREATING CONDITIONS WHERE DAPSONE IS INDICATED.